SA
Sign upLog In

Rocket Pharmaceuticals Inc (RCKT)

SG&A Expenses

$67.52M

TTM · Period ending: · USD

RCKT logo

RCKT SG&A Expenses

Latest reported$67.52M
RCKT TTM SG&A Expenses ($2.11M → $67.52M)
High-resolution chart · PNG

RCKT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rocket Pharmaceuticals Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
67,517,000
75,112,000
86,501,000
97,154,000
105,912,000
107,473,000
100,388,000
96,586,000
88,062,000
78,855,000
73,317,000
70,827,000
67,347,000
62,827,000
58,774,000
51,901,000
46,821,000
43,485,000
42,628,000
38,657,000
34,362,000
31,672,000
27,922,000
24,702,000
23,308,000
20,883,000
17,528,000
15,412,000
13,344,000
13,041,000
17,895,000
18,578,000
20,205,000
18,337,000
12,544,000
11,742,000
10,158,000
10,241,000
9,894,000
9,457,000
8,971,000
8,384,000
7,842,000
6,308,000
5,326,000
3,930,000
2,112,000
1,419,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.